A4 الأكورديون تفاصيل الحدث

2nd Nov 10:00 - 10:30 (CET)

Stand 30J20, Hall 3.1- Keynote

Sustainability Strategies in the Life Sciences Industry

Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.

Register for the event Set a calendar reminder

SPEAKERS

Elon Musk

Acme corp.

Bill Gates

Acme corp.

DISCUSSION POINTS

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet
Lorem ipsum dolor sit amet

TALK SPONSOR

2nd Nov 10:00 - 10:30 (CET)

Stand 30J20, Hall 3.1- Keynote

Sourcing Responsibly – Putting ESG Principles Into Practice

Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.

2nd Nov 10:00 - 10:30 (CET)

Stand 30J20, Hall 3.1- Keynote

Keynote Sustainability

Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.

Register for the event Set a calendar reminder

2nd Nov 10:00 - 10:30 (CET)

Stand 30J20, Hall 3.1- Keynote

Why Biopharma CDMO Companies Must Transition with Long-Term Sustainability in Mind

Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.

Register for the event Set a calendar reminder

2nd Nov 10:00 - 10:30 (CET)

Stand 30J20, Hall 3.1- Keynote

Indena's Commitment to Sustainability: From Responsible Supply Chain Management to Smart Use of Energy, we aim to Protect Nature, People, and Business

Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. He and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.

Register for the event Set a calendar reminder

Component Guide